BZA-DRUG (PH NO.:32058) LEUPROLIDE ACETATE 3.75 MG INJ
STORES/SOUTH CENTRAL RLY · Pharmaceuticals · open
Key facts
- Published: 30 Jul 2026
- Closing date: 07 Sep 2026
- Status: open
Description
Tender for supply of Leuprolide Acetate 3.75 mg injection for South Central Railway stores, with a closing date of 7th September 2026, under limited tender conditions. The tender specifies procurement details, eligibility, and compliance requirements for the drug, including packaging and labeling standards.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
- Certifications: Import license (if applicable), Product packaging and labeling compliance
- Documents required: Railway Board approved product list
Commercial terms
- Bid type: Single Packet
- Evaluation: Itemwise/Consigneewise
- Make in India (MII): No
- MSE preference: No
Line items (1)
- Leuprolide Acetate 3.75 mg injection — Qty: 15 Numbers
5 tender document(s) available — sign up to download.